Most Popular Brands: Fampridine
4-Aminopyridine (4-AP) is a potassium channel blocker. It acts by blocking potassium channels in damaged nerve fibers enabling the axon to transmit nerve impulses again. It has been under study for spinal cord injuries and for Multiple Sclerosis.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Mobility | 53 |
|
|
|
|
|
17 |
| Fatigue | 26 |
|
|
4 | |||
| Other | 24 |
|
|
|
11 | ||
| Stiffness/Spasticity | 13 |
|
|
2 | |||
| Slow my MS progress | 6 | 0 | |||||
| Sensation | 5 |
|
1 |
See all 139 patients currently taking 4-Aminopyridine (4-AP)
Mouse over the table for more information
Top 10 dosages based on patients currently taking 4-Aminopyridine (4-AP). See all 24 dosages ►
| 1other as needed | 20 mg as needed | 5mg as needed | daily | 2 daily | 2 other daily | 3 mg daily | 3.5 mg daily | 5 mg daily | 7.5 mg daily | 10 g daily | 10 mcg daily | 10 mg daily | 12 mg daily | 12.5 mg daily | 15 mg daily | 20 mg daily | 25 mg daily | 30 mg daily | 222 mg weekly | 37.5 mg daily | 40 mg daily | 50 mg daily | 60 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
4
|
1
|
1
|
1
|
27
|
1
|
1
|
10
|
46
|
3
|
25
|
1
|
1
|
5
|
1
|
3
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
11 | 35% |
|
|
Side effects too severe
|
7 | 23% |
|
|
Doctor's advice
|
6 | 19% |
|
|
Other
|
6 | 19% |
|
|
Expense
|
4 | 13% |
|
|
Personal research
|
2 | 6% |
|
|
Course of treatment ended
|
2 | 6% |
|
|
Not indicated
|
1 | 3% |
|
See all 31 patients who’ve stopped taking 4-Aminopyridine (4-AP)
Report created on November 22, 2009.